BrokerBase
  • Home
  • Companies
  • News
Sign In Sign Up
  • Home
  • News
Bank of America Cuts Hims & Hers Price Target Citing Overly Optimistic Forecasts
1 week ago

Bank of America Cuts Hims & Hers Price Target Citing Overly Optimistic Forecasts

Bank of America lowered its price target for Hims & Hers Health to $29, maintaining an Underperform rating, citing overly high consensus expectations for 2026 sales and margins. Separately, Citi noted the company's exclusion from Novo Nordisk's Wegovy partner list.

Read
Coty Completes Wella Sale and Faces Analyst Downgrades After CEO Departure
1 week ago

Coty Completes Wella Sale and Faces Analyst Downgrades After CEO Departure

Coty sold its remaining stake in Wella to KKR for $750 million. Following CEO Sue Nabi's resignation, analysts from Evercore ISI and Grupo Santander downgraded the stock, citing leadership uncertainty.

Read
Unilever Downgraded by BNP Paribas as Jefferies Maintains Underperform Rating
1 week ago

Unilever Downgraded by BNP Paribas as Jefferies Maintains Underperform Rating

BNP Paribas downgraded Unilever from Outperform to Neutral on Jan 8, 2026, with a $71 price target, citing cheap valuations. Jefferies kept its Underperform rating on Jan 7, raising its target to 4,100 GBp, noting earnings challenges. The stock is down 1.65% YTD.

Read
US Foods Secures Major Defense Contract Amid Analyst Price Target Adjustment
1 week ago

US Foods Secures Major Defense Contract Amid Analyst Price Target Adjustment

US Foods Holding Corp. received a $198.26 million defense contract on January 8, 2026, while Citi analyst Karen Holthouse lowered its price target on January 7, 2026.

Read
Millions of Student Loan Borrowers Face Default as Collections Resume
1 week ago

Millions of Student Loan Borrowers Face Default as Collections Resume

Over 5 million federal student loan borrowers were in default as of June 2025, with collections resuming in May. Borrowers risk wage garnishment and credit damage.

Read
Deutsche Bank and Barclays Issue Divergent Views on Kroger Stock
1 week ago

Deutsche Bank and Barclays Issue Divergent Views on Kroger Stock

Deutsche Bank resumed coverage of Kroger with a Buy rating and $75 target, while Barclays cut its target to $68, both citing 2026 economic factors.

Read
Sysco Sees Mixed Analyst Views as Stock Rises in Early 2026
1 week ago

Sysco Sees Mixed Analyst Views as Stock Rises in Early 2026

Citi lowered Sysco's price target to $81 on Jan 7, 2026, while Barclays raised its target to $88. The stock is up 1.11% YTD as of Jan 9.

Read
Deutsche Bank Initiates Coverage on Sprouts Farmers Market with Hold Rating
1 week ago

Deutsche Bank Initiates Coverage on Sprouts Farmers Market with Hold Rating

Deutsche Bank analyst Krisztina Katai began covering Sprouts Farmers Market with a Hold rating and $88 price target on January 8, 2026. Four Corners Property Trust acquired a Sprouts property in Tennessee for $8.6 million on December 31, 2025.

Read
Futurum Group CEO Identifies Five Tech Stocks Poised for Market Leadership in 2026
1 week ago

Futurum Group CEO Identifies Five Tech Stocks Poised for Market Leadership in 2026

Daniel Newman, CEO of The Futurum Group, has named five technology stocks he expects to lead the market by 2026.

Read
Analysts Adjust Domino's Price Targets as Stock Declines
1 week ago

Analysts Adjust Domino's Price Targets as Stock Declines

Two analysts lowered Domino's Pizza price targets in early January 2026, citing industry challenges. The stock has fallen nearly 3% year-to-date.

Read
Mizuho and Wells Fargo Adjust Price Targets for Mondelez International
1 week ago

Mizuho and Wells Fargo Adjust Price Targets for Mondelez International

Mizuho and Wells Fargo analysts lowered Mondelez International's price targets in early January 2026, citing competition and market conditions, as the stock shows a slight year-to-date decline.

Read
General Mills Earnings Beat Estimates as Deutsche Bank Adjusts Price Target
1 week ago

General Mills Earnings Beat Estimates as Deutsche Bank Adjusts Price Target

General Mills reported Q2 earnings above expectations on Dec 17, 2025, with sales of $4.86B. Deutsche Bank raised its price target to $51 on Dec 18.

Read
Albertsons Faces Mixed Analyst Views After Price Target Adjustments
1 week ago

Albertsons Faces Mixed Analyst Views After Price Target Adjustments

On January 8, 2026, BofA lowered Albertsons' price target to $20 and kept a Neutral rating, while Telsey Advisory cut its target to $22 but maintained an Outperform rating, citing Q3 performance driven by digital and pharmacy growth.

Read
Intuitive Surgical Shares Fall Despite Sales Beat
1 week ago

Intuitive Surgical Shares Fall Despite Sales Beat

Intuitive Surgical stock dropped 5.8% after pre-announcing Q4 sales above analyst estimates, as procedure growth slowed and management forecast further deceleration for 2026.

Read
Wingstop Receives Mixed Analyst Price Target Adjustments Amid 2026 Outlook
1 week ago

Wingstop Receives Mixed Analyst Price Target Adjustments Amid 2026 Outlook

On January 7, 2026, Stifel lowered Wingstop's price target to $290 while Barclays raised it to $335, both citing 2026 restaurant industry challenges. The stock had surged 18% in November after strong quarterly results.

Read
« Previous Next »

Trending News

01
Jim Cramer Discusses CoreWeave Amid Trump Bond Purchase Reports
Jan 24
02
Oakmark Fund Outperforms S&P 500 in Q4 2025, Highlights Fiserv as Top Detractor
Jan 14
03
Roblox Stock Surges Ahead of 2026 Earnings Report
Jan 14
04
Bitcoin Shows Signs of Consolidation as Key Indicators Align
Jan 21
05
CarGurus CEO Outlines Software Shift and AI Expansion at Industry Conference
Jan 14
06
Nvidia Faces Future Challenges Amid AI Dominance
Jan 17
07
Nu Holdings Stock Surges as Digital Bank Expands Customer Base and Revenue
Jan 18
BrokerBase
BrokerBase

Contact us: support@brokerbase.co

Information is collected from public sources and user feedback.

Data status Updated

Broker information is reviewed and updated regularly.

Explore

  • Companies
  • News
  • Sitemap

Legal

  • Disclaimer
  • Privacy Policy
  • Terms of Use

© 2026 BrokerBase. All rights reserved.

BrokerBase does not provide investment advice. All content is for informational and reference purposes only. Users should verify information independently before making decisions.